sunlenca
gilead sciences ireland unlimited company - lenacapavir sodium - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 og 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 og 5.
aripiprazol w&h tafla 15 mg
williams & halls ehf. - aripiprazolum inn - tafla - 15 mg
sporanox hart hylki 100 mg
janssen-cilag ab - itraconazolum inn - hart hylki - 100 mg
aripiprazol w&h tafla 5 mg
williams & halls ehf. - aripiprazolum inn - tafla - 5 mg
aripiprazol w&h tafla 10 mg
williams & halls ehf. - aripiprazolum inn - tafla - 10 mg
dexamethasone krka tafla 4 mg
krka, d.d., novo mesto - dexamethasonum fosfat - tafla - 4 mg
tegretol mixtúra, dreifa 20 mg/ml
novartis healthcare a/s - carbamazepinum inn - mixtúra, dreifa - 20 mg/ml
tegretol tafla 200 mg
novartis healthcare a/s - carbamazepinum inn - tafla - 200 mg
tegretol retard forðatafla 200 mg
novartis healthcare a/s - carbamazepinum inn - forðatafla - 200 mg
tegretol retard forðatafla 400 mg
novartis healthcare a/s - carbamazepinum inn - forðatafla - 400 mg